SECUKINUMAB, A HUMAN ANTI-INTERLEUKIN-17A MONOCLONAL ANTIBODY, IMPROVES ACTIVE PSORIATIC ARTHRITIS AND INHIBITS RADIOGRAPHIC PROGRESSION: EFFICACY AND SAFETY DATA FROM A PHASE 3 RANDOMIZED, MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Author(s):
Tahir, H.; Mease, P.; McInnes, I.B.; Kirkham, B.; Kavanaugh, A.; Rahman, P.; Heijde, D. van der; Landewe, R.; Nash, P.; Pricop, L.; Yuan, J.; Richards, H.; Mpofu, S.
